i2o Therapeutics is a company that develops an ionic liquid technology intended to develop the effective oral formulation. Its technology leverages the benefits of protecting the drug cargo and enhancing permeation across the epithelial lining, enabling people to intake peptides, proteins, and other injection-based drugs.